ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1,831 Cr | ₹-1,198 Cr | ₹-1,068 Cr | ₹-942 Cr | ₹-955 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1,831 Cr |
| Mar2024 | ₹-1,198 Cr |
| Mar2023 | ₹-1,068 Cr |
| Mar2022 | ₹-942 Cr |
| Mar2021 | ₹-955 Cr |
How is Deferred Tax Assets / Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,831 Cr | Negative | |
| Mar2024 | ₹-1,198 Cr | Negative | |
| Mar2023 | ₹-1,068 Cr | Negative | |
| Mar2022 | ₹-942 Cr | Negative | |
| Mar2021 | ₹-955 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹91,428.4 Cr | 0.2% | 0.4% | 4.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 0.2% |
0.4% |
4.9% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses